Search research articles
Contact Us
Filters
Showing results (661-670 of 1,119) with videos related to
Page
of 112
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes
|
February 14, 2018
Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry
Rong Bing, Shaun G Goodman, Andrew T Yan, et al.
The American Journal of Medicine
|
July 6, 2004
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study
Kim A Eagle, Eva Kline-Rogers, Shaun G Goodman, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 18, 2014
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study
Akshay Bagai, Eric D Peterson, Emily Honeycutt, et al.
American Heart Journal
|
November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events
Matthew Sibbald, Andrew T Yan, Wei Huang, et al.
Journal of the American Heart Association
|
January 22, 2017
Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization
Jacob A Udell, Maria Koh, Feng Qiu, et al.
Canadian Journal of Diabetes
|
April 11, 2021
Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey
Hirmand Nouraei, Lawrence A Leiter, Mary K Tan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 1, 1987
Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis
G M Shah, R L Winer, R E Cutler, et al.
BMC Surgery
|
October 16, 2015
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
Subodh Verma, Shaun G Goodman, Shamir R Mehta, et al.
JACC. Advances
|
November 4, 2024
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity
Konstantin A Krychtiuk, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal
|
November 18, 2024
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS
Alexander C Fanaroff, Amit N Vora, Daniel M Wojdyla, et al.
Page
of 112
Search research articles
Search
Showing results (661-670 of 1,119) with videos related to
Sort By:
Page
of 112
European Heart Journal. Quality of Care & Clinical Outcomes
|
February 14, 2018
Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry
Rong Bing, Shaun G Goodman, Andrew T Yan, et al.
The American Journal of Medicine
|
July 6, 2004
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study
Kim A Eagle, Eva Kline-Rogers, Shaun G Goodman, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 18, 2014
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study
Akshay Bagai, Eric D Peterson, Emily Honeycutt, et al.
American Heart Journal
|
November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events
Matthew Sibbald, Andrew T Yan, Wei Huang, et al.
Journal of the American Heart Association
|
January 22, 2017
Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization
Jacob A Udell, Maria Koh, Feng Qiu, et al.
Canadian Journal of Diabetes
|
April 11, 2021
Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey
Hirmand Nouraei, Lawrence A Leiter, Mary K Tan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 1, 1987
Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis
G M Shah, R L Winer, R E Cutler, et al.
BMC Surgery
|
October 16, 2015
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
Subodh Verma, Shaun G Goodman, Shamir R Mehta, et al.
JACC. Advances
|
November 4, 2024
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity
Konstantin A Krychtiuk, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal
|
November 18, 2024
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS
Alexander C Fanaroff, Amit N Vora, Daniel M Wojdyla, et al.
Page
of 112